These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8028997)

  • 21. [Signal transduction of growth factor mediated by heparin/heparan sulfate].
    Iwasaki W; Inagaki F
    Tanpakushitsu Kakusan Koso; 2001 Oct; 46(13):1922-8. PubMed ID: 11593742
    [No Abstract]   [Full Text] [Related]  

  • 22. 'Heparin'--from anticoagulant drug into the new biology.
    Lindahl U
    Glycoconj J; 2000; 17(7-9):597-605. PubMed ID: 11421351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semi-synthetic heparin derivatives: chemical modifications of heparin beyond chain length, sulfate substitution pattern and N-sulfo/N-acetyl groups.
    Fernández C; Hattan CM; Kerns RJ
    Carbohydr Res; 2006 Jul; 341(10):1253-65. PubMed ID: 16712822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into the role of heparan sulphate in fibroblast growth factor signalling.
    Harmer NJ
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):442-5. PubMed ID: 16709182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Great Scandinavian Jahre Prize 1993. Studies of cartilage and bone yields new knowledge of tissue homeostasis].
    Heinegård D
    Nord Med; 1994; 109(2):40-3. PubMed ID: 8121785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoenzymatic synthesis of heparan sulfate and heparin.
    Liu J; Linhardt RJ
    Nat Prod Rep; 2014 Dec; 31(12):1676-85. PubMed ID: 25197032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimum fragments of the heparin molecule able to produce the accumulation and change of the sulfation pattern of an antithrombotic heparan sulfate from endothelial cells.
    Pinhal MA; Santos IA; Silva IF; Dietrich CP; Nader HB
    Thromb Haemost; 1995 Oct; 74(4):1169-74. PubMed ID: 8560430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence analysis of heparan sulphate and heparin oligosaccharides.
    Vivès RR; Pye DA; Salmivirta M; Hopwood JJ; Lindahl U; Gallagher JT
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):767-73. PubMed ID: 10215618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The activities of heparan sulfate and its analogue heparin are dictated by biosynthesis, sequence, and conformation.
    Skidmore MA; Guimond SE; Rudd TR; Fernig DG; Turnbull JE; Yates EA
    Connect Tissue Res; 2008; 49(3):140-4. PubMed ID: 18661329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes.
    Tyler-Cross R; Sobel M; McAdory LE; Harris RB
    Arch Biochem Biophys; 1996 Oct; 334(2):206-13. PubMed ID: 8900394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism.
    Rosenberg RD
    Am J Med; 1989 Sep; 87(3B):2S-9S. PubMed ID: 2679066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ZNF263 is a transcriptional regulator of heparin and heparan sulfate biosynthesis.
    Weiss RJ; Spahn PN; Toledo AG; Chiang AWT; Kellman BP; Li J; Benner C; Glass CK; Gordts PLSM; Lewis NE; Esko JD
    Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9311-9317. PubMed ID: 32277030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assays and reference materials for current and future applications of heparins.
    Mulloy B; Hogwood J; Gray E
    Biologicals; 2010 Jul; 38(4):459-66. PubMed ID: 20338781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of lipoprotein lipase with heparin fragments and with heparan sulfate: stoichiometry, stabilization, and kinetics.
    Lookene A; Chevreuil O; Ostergaard P; Olivecrona G
    Biochemistry; 1996 Sep; 35(37):12155-63. PubMed ID: 8810923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.
    Graham LD; Whitelock JM; Underwood PA
    Biochem Biophys Res Commun; 1999 Mar; 256(3):542-8. PubMed ID: 10080934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomness in the heparin polymer: computer simulations of alternative action patterns of heparin lyase.
    Cohen DM; Linhardt RJ
    Biopolymers; 1990; 30(7-8):733-41. PubMed ID: 2275975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the mouse mastocytoma glucosaminyl N-deacetylase/ N-sulfotransferase in human kidney 293 cells results in increased N-sulfation of heparan sulfate.
    Cheung WF; Eriksson I; Kusche-Gullberg M; Lindhal U; Kjellén L
    Biochemistry; 1996 Apr; 35(16):5250-6. PubMed ID: 8611511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin, heparan sulfate and heparanase in inflammatory reactions.
    Li JP; Vlodavsky I
    Thromb Haemost; 2009 Nov; 102(5):823-8. PubMed ID: 19888515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of low-molecular-weight heparin/heparan sulfate from marine sources.
    Saravanan R
    Adv Food Nutr Res; 2014; 72():45-60. PubMed ID: 25081076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin/heparan sulphate-based drugs.
    Gandhi NS; Mancera RL
    Drug Discov Today; 2010 Dec; 15(23-24):1058-69. PubMed ID: 20974281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.